title: Prophylaxis versus preemptive protocols for CMV: do they impact graft survival?
authors.forename: G G
authors.initials: GG
authors.lastname: Miller
authors.forename: B
authors.initials: B
authors.lastname: Kaplan
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D003586:Cytomegalovirus Infections / Q000517:prevention & control*; D006085:Graft Survival; D006801:Humans; D016030:Kidney Transplantation / Q000009:adverse effects / Q000502:physiology*; D011183:Postoperative Complications / Q000517:prevention & control / Q000821:virology; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome
chemical_list: D000998:Antiviral Agents